Bioconjugate Chemistry · 2006 · 99 citations · 13 references
PharmacyPharmaceuticsPharmacokineticsDrug DeliveryNanoparticle Drug DeliveryTargeted Drug DeliveryLipid ChemistryLipid-based Drug Delivery SystemsLipid-based NanoparticlesLiposomal FormulationsLiposome-based DeliveryNanocarriers For TherapeuticsBoron IncorporationCellular Uptake Of LiposomesLiposomal NanocarriersLiposomesNeutron IrradiationNeutron Irradiation EffectsSurvival RatesTargeted Liposomes
The nido-carborane lipid 2 as a double-tailed boron lipid was synthesized from heptadecanol in five steps. The lipid 2 formed stable liposomes at 25% molar ratio toward DSPC with cholesterol. Transferrin was able to be introduced on the surface of boron liposomes (Tf(+)-PEG-CL liposomes) by the coupling of transferrin to the PEG-CO(2)H moieties of Tf(-)-PEG-CL liposomes. The biodistribution of Tf(+)-PEG-CL liposomes, in which (125)I-tyraminyl inulins were encapsulated, showed that Tf(+)-PEG-CL liposomes accumulated in tumor tissues and stayed there for a sufficiently long time to increase tumor/blood concentration ratio, although Tf(-)-PEG-CL liposomes were gradually released from tumor tissues with time. A boron concentration of 22 ppm in tumor tissues was achieved by the injection of Tf(+)-PEG-CL liposomes at 7.2 mg/kg body weight boron in tumor-bearing mice. After neutron irradiation, the average survival rate of mice not treated with Tf(+)-PEG-CL liposomes was 21 days, whereas that of the treated mice was 31 days. Longer survival rates were observed in the mice treated with Tf(+)-PEG-CL liposomes; one of them even survived for 52 days after BNCT.
13
Kazuo Maruyama, Tomoko Takizawa, Tsutomu Yuda et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 1995 · 264 citations
Pharmacy, Immunology, Pharmaceutics +12
Kazuo Maruyama, Osamu Ishida, Satoshi Kasaoka et al. · Journal of Controlled Release · 2004 · 204 citations
Pharmacy, Cancer Biology, Oncology +17